Nitrous Oxide for the Treatment of Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

June 10, 2023

Study Completion Date

December 10, 2023

Conditions
DepressionMajor Depressive Disorder
Interventions
DRUG

Nitrous Oxide

1-hour sessions of inhaled nitrous oxide at concentrations of 25% or 50% (randomly assigned) to be administered weekly for 4 weeks.

DRUG

Placebo

1-hour sessions of inhaled oxygen-air mixture (inspired oxygen concentration \~23-30%) to be administered weekly for 4 weeks.

Trial Locations (2)

3004

Alfred Hospital, Melbourne

60637

University of Chicago Medicine, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayside Health

OTHER_GOV

NCT03869736 - Nitrous Oxide for the Treatment of Major Depressive Disorder | Biotech Hunter | Biotech Hunter